Are you Hyun Yul Nam?

Claim your profile

Publications (2)9.78 Total impact

  • Article: Double-phase 18F-FDG PET-CT for determination of pulmonary tuberculoma activity.
    [show abstract] [hide abstract]
    ABSTRACT: The aim of this study is to evaluate the potential role of double phase acquisition of (18)F fluorodeoxyglucose (FDG) positron emission tomography (PET) for the differentiation of active pulmonary tuberculoma. A total of 25 consecutive patients with pulmonary tuberculoma were enrolled. PET/CT imaging was performed 60 (range 53-71) and 120 min (range 109-131) after injection of (18)F-FDG. The intensity of (18)F-FDG uptake by pulmonary lesions was assessed visually, and the intensity was scored with a four-point scale (grade 1: absent, grade 2: faint, grade 3: moderate, grade 4: intense). Active tuberculoma shows statistically significant higher values in maximal standardized uptake values SUV(maxE) (active = 2.3 +/- 0.75, inactive = 0.79 +/- 0.15), SUV(maxD) (active = 2.48 +/- 0.79, inactive = 0.75 +/- 0.13), and %DeltaSUV(max) (active = 8.07 +/- 7.77%, inactive = -3.83 +/- 6.59) than those of inactive tuberculoma. When greater than or equal to visual grade 2 was used as the cutoff value, the sensitivity and specificity were 100 and 81.8%. When SUV(maxE) 1.05 was used as the cutoff point, the sensitivity and specificity were 100 and 100%. When SUV(maxD) 0.97 was used as the cutoff value, the sensitivity and specificity were 92.8 and 100%. When %DeltaSUV(max) 6.59 was used as the cutoff value, the sensitivity and specificity were 71.4 and 100%. The %DeltaSUV(max) was the potent predictor by logistic regression analysis. The DeltaSUV(max) is a potential predictor for activity of pulmonary tuberculoma. However, the diagnostic performances were similar between visual and quantitative analyses. The visual assessment may be sufficient for determination of pulmonary tuberculoma activity. Further studies are needed to confirm these results and improve statistical accuracy.
    European journal of nuclear medicine and molecular imaging 05/2008; 35(4):808-14. · 4.99 Impact Factor
  • Article: Limited cytoprotective effects of amifostine in high-dose radioactive iodine 131-treated well-differentiated thyroid cancer patients: analysis of quantitative salivary scan.
    [show abstract] [hide abstract]
    ABSTRACT: The aim of present study was to investigate the cytoprotective effect of amifostine on salivary glands in 131I-treated differentiated thyroid cancer (DTC) patients using serial quantitative analysis of salivary gland scans. Serial quantitative salivary scintigraphies were performed in 80 newly diagnosed DTC patients (9 men, 71 women; mean age, 43.2 years old; range, 21-58 years old). Forty-two patients were assigned randomly to the amifostine treatment group, which received 300 mg/m2 amifostine intravenously before 131I administration. In both amifostine-treated and nontreated groups statistically significant declines of functional parameters after 131I treatment were revealed by quantitative salivary scintigraphy in DTC patients. Amifostine pretreatment did not prevent the parenchymal damage to major salivary gland function after 131I treatment (F = 1.37, p = 0.2461). However, the dose of 131I had significant effects on salivary gland function after 131I treatment (F = 9.72, p = 0.0002). The present study did not show cytoprotective effects of amifostine for DTC patients treated with 131I.
    Thyroid 04/2008; 18(3):325-31. · 4.79 Impact Factor